perferryl-iron has been researched along with Anemia* in 4 studies
1 trial(s) available for perferryl-iron and Anemia
Article | Year |
---|---|
Intravenous iron administration before cardiac surgery reduces red blood cell transfusion in patients without anaemia.
Reducing the need for blood transfusion among patients undergoing cardiac surgery FLA reduce postoperative complications and mortality. Our study aimed to assess the effects of administering preoperative i.v. ferric carboxymaltose on postoperative red cell transfusion requirements in patients without anaemia undergoing on-pump cardiac surgery.. This double-blind, randomised, placebo-controlled trial was conducted between October 2016 and November 2019, with a follow-up period of up to 6 weeks after surgery. Patients without anaemia who underwent on-pump cardiac surgery were included as participants and administered i.v. iron in the form of ferric carboxymaltose or placebo once, 24-72 h before surgery. The primary outcome was the number of red cell units transfused during the first four postoperative days, and the secondary outcome measures were blood haemoglobin concentrations at 4 days and 6 weeks after surgery.. In patients without anaemia undergoing on-pump cardiac surgery, treatment with a single dose of 1000 mg ferric carboxymaltose i.v. 1-3 days before surgery significantly reduced the need for red cell transfusions and increased the postoperative haemoglobin concentration.. NCT02939794. Topics: Administration, Intravenous; Anemia; Cardiac Surgical Procedures; Double-Blind Method; Erythrocyte Transfusion; Ferric Compounds; Hemoglobins; Humans; Iron; Maltose | 2023 |
3 other study(ies) available for perferryl-iron and Anemia
Article | Year |
---|---|
Comparative analysis of oral and intravenous iron therapy in rat models of inflammatory anemia and iron deficiency.
Anemia is a major health issue and associated with increased morbidity. Iron deficiency anemia (IDA) is the most prevalent, followed by anemia of chronic disease (ACD). IDA and ACD often co-exist, challenging diagnosis and treatment. While iron supplementation is the first-line therapy for IDA, its optimal route of administration and the efficacy of different repletion strategies in ACD are elusive. Female Lewis rats were injected with group A streptococcal peptidoglycan-polysaccharide (PG-APS) to induce inflammatory arthritis with associated ACD and/or repeatedly phlebotomized and fed with a low iron diet to induce IDA, or a combination thereof (ACD/IDA). Iron was either supplemented by daily oral gavage of ferric maltol or by weekly intravenous (i.v.) injection of ferric carboxymaltose for up to 4 weeks. While both strategies reversed IDA, they remained ineffective to improve hemoglobin (Hb) levels in ACD, although oral iron showed slight amelioration of various erythropoiesis-associated parameters. In contrast, both iron treatments significantly increased Hb in ACD/IDA. In ACD and ACD/IDA animals, i.v. iron administration resulted in iron trapping in liver and splenic macrophages, induction of ferritin expression and increased circulating levels of the iron hormone hepcidin and the inflammatory cytokine interleukin-6, while oral iron supplementation reduced interleukin-6 levels. Thus, oral and i.v. iron resulted in divergent effects on systemic and tissue iron homeostasis and inflammation. Our results indicate that both iron supplements improve Hb in ACD/IDA, but are ineffective in ACD with pronounced inflammation, and that under the latter condition, i.v. iron is trapped in macrophages and may enhance inflammation. Topics: Anemia; Anemia, Iron-Deficiency; Animals; Female; Inflammation; Interleukin-6; Iron; Rats; Rats, Inbred Lew | 2023 |
Impact of postoperative intravenous iron therapy on postoperative infections in older patients with severe anaemia after hip fracture surgery.
Anaemia is common following hip fracture in ortho-geriatric patients and is associated with postoperative infections.. This study investigated whether intravenous iron supplements reduced the rate of postoperative infections within 30 days postoperatively in older adults after hip fracture surgery.. The patients were divided into four treatment groups: blood transfusion (n = 44), IV iron (n = 69), blood transfusion + IV iron (n = 35) and no treatment (n = 50). The number of patients who had an infection within 30 days was similar in the two time periods (38.8% before vs. 38.9% after systematic I.V. iron supplementation, P = 1.00) and no significant difference according to risk of infection was found between treatment groups.. This study documents no effect of intravenous iron supplements on postoperative infections in older adults after hip fracture surgery.. The study was registered with the Danish Data Protection Authority (2008-58-0028) the 2 Topics: Aged; Anemia; Hip Fractures; Humans; Iron; Postoperative Complications | 2023 |
[Analytic study of iron metabolism in normal and pathological conditions. Clinical research conducted with the aid of iron 59. V. The metabolism of iron in patients with iron-protein-deficiency anemia].
Topics: Anemia; Anemia, Hypochromic; Anemia, Iron-Deficiency; Hematologic Diseases; Humans; Iron; Protein Deficiency | 1959 |